Home > Share Market > Stocks > Venus remedies > Financial Statements > VENUSREM Key Financial Ratios

Venus remedies Financial Statements

Venus remedies Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 61.50 (8.90) (6.90) (4.40)
Op profit growth 31.70 3.41 (22) (38)
EBIT growth 170 78.80 (38) (69)
Net profit growth (718) (67) 79.70 (1,105)
Profitability ratios (%)        
OPM 9.81 12 10.60 12.70
EBIT margin 6.96 4.16 2.12 3.18
Net profit margin 11.30 (2.90) (8.20) (4.30)
RoCE 7.51 2.27 1.13 1.69
RoNW 4.27 (0.70) (2) (1)
RoA 3.04 (0.40) (1.10) (0.60)
Per share ratios ()        
EPS 50 (8.10) -- --
Dividend per share -- -- -- --
Cash EPS 21.50 (34) (52) (46)
Book value per share 324 262 293 315
Valuation ratios        
P/E 5.49 (2.80) -- --
P/CEPS 12.80 (0.70) (1.30) (2.10)
P/B 0.85 0.09 0.22 0.31
EV/EBIDTA 4.92 5.34 9.20 8.10
Payout (%)        
Dividend payout -- -- -- --
Tax payout 52.60 (253) 11.50 (21)
Liquidity ratios        
Debtor days 20.90 41.90 46.30 49.70
Inventory days 86.90 150 137 130
Creditor days (40) (41) (33) (29)
Leverage ratios        
Interest coverage (2.90) (1.10) (0.20) (0.40)
Net debt / equity 0.06 0.68 0.84 0.79
Net debt / op. profit 0.42 5.35 7.67 6.07
Cost breakup ()        
Material costs (62) (51) (55) (57)
Employee costs (8.40) (14) (11) (8.60)
Other costs (20) (23) (24) (22)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000